PROVIDER PROFILE · NPI 1356946420
Geena Eglin
PRESCRIBING · PART D · 2024
Total Rx claims
746
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
22
Brand share
90.2%
Top prescribed drugs
Evolocumab133 claims
Bempedoic Acid78 claims
Teriparatide67 claims
Alirocumab52 claims
Ezetimibe49 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE